As NCI's all-consumer advisory body, the Director's Consumer Liaison Group makes recommendations to the Director of NCI from the consumer advocate perspective on a wide variety of issues, programs, and research priorities. Liaison Activities . NCI's Liaison Activities supports the Institute's research and related programs by fostering strong communications and relationships with the cancer advocacy community, professional societies, scientific organizations and federal agencies. The Cancer Information Service Partnership Program works with organizations that reach minority and medically underserved audiences that have limited access to health information and services to increase the public's awareness of and understanding about cancer. Partner organizations recruited community leaders who attended training programs and encouraged their communities to consider participating in clinical trials.
Evaluation is ongoing.
In addition, NCI is developing a new series of clinical trial education and outreach materials based on the lessons learned in the pilot campaign. Materials will be available in fall 2001. Industry collaborations accelerate the progress of cancer research by pooling government and private resources. These agreements contribute to the commercialization and distribution of federally-developed technologies. The Developmental Therapeutics Program evaluates new agents, many from private companies, at the pre-clinical level.